Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
DYAI	DYADIC INTERNATIONAL INC	$38.00M	-355.30%	-60.70%	-113.79%	-79.20%	-16.36	2.02	59.90%	-134.80%	-123.19%
ADXN	ADDEX THERAPEUTICS LTD	$7.43M	-66.80%	-59.30%	-82.04%	-95.50%	0.18	2.31	100.00%	-3,616.40%	-3,607.23%
ANEB	ANEBULO PHARMACEUTICALS INC	$95.32M	-80.80%	-76.30%	-69.50%	-4,829.60%	0.04	24.53	N/A	N/A	N/A
XBIO	XENETIC BIOSCIENCES INC	$9.76M	-54.50%	-47.30%	-69.28%	3,722.20%	0.20	5.93	100.00%	-126.00%	-126.03%
AKTX	AKARI THERAPEUTICS PLC	$60.66M	-78.00%	-31.60%	-35.44%	83.00%	0.99	0.19	N/A	N/A	N/A
CHEK	CHECK-CAP LTD	$10.77M	-226.20%	-198.10%	1,809.55%	-390.80%	-1.26	0.15	N/A	N/A	N/A
ABP	ABPRO HOLDINGS INC	$14.75M	N/A	-628.00%	65.76%	84.40%	-1.17	0.15	100.00%	-12,282.00%	-6,089.62%
EPRX	EUPRAXIA PHARMACEUTICALS INC	$218.27M	-123.50%	-118.40%	-138.38%	13,065.60%	0.12	8.72	N/A	N/A	N/A
XCUR	EXICURE INC	$26.98M	-110.00%	-41.10%	-34.76%	-79.40%	0.82	2.91	N/A	N/A	N/A
INAB	IN8BIO INC	$9.53M	-183.10%	-125.50%	-137.16%	-226.60%	0.27	7.03	N/A	N/A	N/A
FORA	FORIAN INC	$71.87M	-3.10%	-1.80%	-1.31%	-1.10%	0.57	2.66	59.30%	-3.60%	-1.62%
ANL	ADLAI NORTYE LTD	$57.88M	-98.90%	-51.50%	-192.69%	-828.00%	1.80	1.41	N/A	N/A	N/A
XRTX	XORTX THERAPEUTICS INC	$3.34M	-73.50%	-53.00%	-92.63%	-383.60%	0.35	1.78	N/A	N/A	N/A
APLM	APOLLOMICS INC	$20.34M	-233.70%	-157.30%	-937.36%	2,070.90%	1.69	1.39	N/A	N/A	N/A
XTLB	XTL BIOPHARMACEUTICALS LTD	$12.34M	-26.80%	-18.70%	-18.24%	911.00%	0.57	0.61	0.70%	-227.70%	-256.54%
XTNT	XTANT MEDICAL HOLDINGS INC	$93.31M	-10.10%	-4.70%	0.16%	0.10%	1.13	2.47	60.20%	-3.60%	0.09%
XWEL	XWELL INC	$5.70M	N/A	-77.70%	-148.43%	-94.40%	-3.54	1.25	20.50%	-67.60%	-62.91%
YCBD	CBDMD INC	$10.96M	-184.40%	-45.20%	-24.47%	-253.70%	0.62	N/A	61.20%	-25.50%	-8.12%
YDES	YD BIOPHARMA LTD	$1.22B	N/A	-12.30%	-20.99%	401.50%	0.04	13.18	30.40%	-276.60%	-271.52%
CAMP	CAMP4 THERAPEUTICS CORP	$74.80M	N/A	-96.90%	-117.85%	-409.10%	0.28	5.60	100.00%	-1,722.10%	-1,722.08%
ENVB	ENVERIC BIOSCIENCES INC	$2.03M	-341.50%	-240.70%	-454.80%	4,067.80%	0.62	2.43	N/A	N/A	N/A
BYSI	BEYONDSPRING INC	$70.18M	N/A	-4.60%	-5.45%	-11.50%	-1.61	2.19	100.00%	119.00%	105.20%
DRMA	DERMATA THERAPEUTICS INC	$2.83M	-215.00%	-153.80%	N/A	-3,035.10%	0.18	N/A	N/A	N/A	N/A
GLTO	GALECTO INC	$16.77M	-108.10%	-95.40%	-149.96%	-1,120.10%	0.25	4.96	N/A	N/A	N/A
AMS	AMERICAN SHARED HOSPITAL SERVICES	$14.97M	-9.70%	-3.90%	-3.23%	-2.40%	1.42	1.17	24.40%	-8.30%	-4.71%
ZCMD	ZHONGCHAO INC	$18.97M	-9.00%	-6.70%	-4.34%	-6.80%	0.13	8.15	52.50%	-12.90%	-7.92%
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$8.61M	-85.30%	-81.50%	-75.55%	3,422.40%	0.04	27.39	60.00%	-43,500.20%	-43,500.24%
CPHI	CHINA PHARMA HOLDINGS INC	$5.94M	-52.80%	-26.00%	-41.53%	-58.30%	1.13	0.51	-20.50%	-83.20%	-80.46%
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	$7.32M	-72.80%	-66.20%	-62.17%	-285.40%	0.07	23.55	100.00%	-32,040.50%	-31,956.48%
BOLD	BOUNDLESS BIO INC	$28.43M	-44.80%	-34.20%	-37.82%	-33.60%	0.46	14.08	N/A	N/A	N/A
ATHA	ATHIRA PHARMA INC	$14.99M	-139.40%	-106.80%	-183.80%	-4,338.00%	0.11	10.81	N/A	N/A	N/A
BMRA	BIOMERICA INC	$7.97M	-99.00%	-69.90%	-118.24%	-168.10%	0.45	2.80	9.40%	-93.60%	-93.62%
INM	INMED PHARMACEUTICALS INC	$5.06M	-93.20%	-74.50%	-56.70%	-384.90%	0.16	6.99	34.50%	-165.10%	-157.62%
BEAT	HEARTBEAM INC	$56.61M	-448.00%	-325.20%	-486.47%	-3,426.40%	0.43	2.98	N/A	N/A	N/A
CRIS	CURIS INC	$19.00M	N/A	-102.20%	-394.64%	640.90%	-3.09	0.74	99.40%	-341.20%	-341.25%
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	$55.38M	-54.80%	-44.70%	-59.42%	-256.10%	0.27	7.89	100.00%	-463.80%	-463.75%
ZJYL	JIN MEDICAL INTERNATIONAL LTD	$66.06M	6.60%	4.00%	8.16%	7.90%	0.74	2.11	35.80%	7.90%	9.93%
ENSC	ENSYSCE BIOSCIENCES INC	$6.68M	-154.40%	-104.60%	-214.27%	-605.10%	0.74	2.10	N/A	N/A	N/A
LSTA	LISATA THERAPEUTICS INC	$20.38M	-60.90%	-53.40%	-80.52%	-197.00%	0.15	7.52	100.00%	-1,930.80%	-2,027.00%
CPIX	CUMBERLAND PHARMACEUTICALS INC	$51.62M	-12.80%	-4.40%	-5.98%	-9.20%	1.45	1.25	84.30%	-8.00%	-6.46%
ZIMV	ZIMVIE INC	$534.69M	-4.90%	-2.60%	1.22%	1.80%	0.84	2.37	65.30%	-4.40%	1.79%
CANF	CAN-FITE BIOPHARMA LTD	$6.31M	-264.10%	-129.00%	-157.13%	1,180.30%	0.85	3.60	100.00%	-1,571.30%	-1,571.25%
ELAB	PMGC HOLDINGS INC	$2.32M	-69.20%	-58.30%	-54.32%	-846.80%	0.04	22.38	72.50%	459.50%	402.88%
CALC	CALCIMEDICA INC	$44.22M	-206.50%	-103.80%	-128.84%	-172.70%	2.13	5.45	N/A	N/A	N/A
MNDR	MOBILE-HEALTH NETWORK SOLUTIONS	$3.10M	-1,216.30%	-388.00%	-561.65%	2,240.40%	0.69	2.04	211.00%	-131.40%	-131.54%
BOLT	BOLT BIOTHERAPEUTICS INC	$11.13M	-94.40%	-54.80%	-80.26%	-55.60%	0.94	3.11	100.00%	-1,217.00%	-1,217.01%
BFRI	BIOFRONTERA INC	$10.24M	-1,151.40%	-85.80%	-3,586.59%	-217.60%	-5.32	0.96	59.00%	-42.30%	-41.64%
ZTEK	ZENTEK LTD	$81.67M	-55.70%	-45.90%	-55.76%	-55.90%	0.32	1.62	24.60%	-956.80%	-945.83%
BDRX	BIODEXA PHARMACEUTICALS PLC	$0.00	-244.80%	-171.40%	-217.16%	-1,804.70%	0.30	3.63	100.00%	-3,171.60%	-3,445.89%
DWTX	DOGWOOD THERAPEUTICS INC	$10.26M	-2,213.60%	-36.50%	-25.72%	-786.90%	2.06	7.80	N/A	N/A	N/A
BFRG	BULLFROG AI HOLDINGS INC	$13.31M	-196.10%	-163.00%	-316.90%	1,998.80%	0.31	3.97	19.60%	-20,966.10%	-20,849.86%
DHAI	DIH HOLDING US INC	$8.76M	N/A	-23.80%	41.23%	-3,296.40%	-1.84	0.51	48.60%	-12.70%	-9.46%
BLRX	BIOLINERX LTD	$18.53M	-49.70%	-17.50%	-3.67%	-12.90%	1.16	2.06	59.30%	-45.30%	-5.92%
BJDX	BLUEJAY DIAGNOSTICS INC	$4.77M	-362.00%	-299.10%	-122.03%	-461.20%	0.21	4.56	N/A	N/A	N/A
CNTX	CONTEXT THERAPEUTICS INC	$125.59M	-38.80%	-37.50%	-41.42%	-7,764.60%	0.06	19.09	N/A	N/A	N/A
ZYXI	ZYNEX INC	$41.81M	-122.60%	-26.10%	-166.79%	-21.40%	67.15	0.62	75.40%	-19.80%	-13.91%
BCDA	BIOCARDIA INC	$7.77M	-19,117.40%	-246.90%	566.26%	1,025.50%	-2.11	0.33	N/A	N/A	N/A
BBLG	BONE BIOLOGICS CORP	$4.36M	-177.20%	-164.30%	-63.98%	-3,346.40%	0.06	17.24	N/A	N/A	N/A
AZTR	AZITRA INC	$2.43M	-183.60%	-138.70%	-373.04%	-556.90%	0.78	1.24	N/A	N/A	N/A
CCEL	CRYO CELL INTERNATIONAL INC	$35.69M	N/A	-0.30%	9.30%	7.40%	-5.14	0.60	76.20%	-0.50%	12.41%
INTS	INTENSITY THERAPEUTICS INC	$14.35M	-612.40%	-287.40%	-551.91%	-9,214.70%	1.03	1.40	N/A	N/A	N/A
CASI	CASI PHARMACEUTICALS INC	$30.70M	N/A	-99.10%	699.22%	-334.00%	-2.54	0.48	41.00%	-148.60%	-144.77%
GTBP	GT BIOPHARMA INC	$2.42M	-1,643.00%	-182.50%	-195.04%	267.10%	1.49	3.09	N/A	N/A	N/A
APYX	APYX MEDICAL CORP	$112.25M	-158.70%	-31.90%	-27.45%	-22.90%	4.71	5.45	61.50%	-42.40%	-29.40%
ICCC	IMMUCELL CORP	$61.51M	6.20%	3.90%	4.19%	3.40%	0.56	3.85	37.40%	6.20%	6.27%
GNPX	GENPREX INC	$6.86M	-822.20%	-393.20%	-1,242.53%	-10,819.70%	1.75	0.84	N/A	N/A	N/A
NDRA	ENDRA LIFE SCIENCES INC	$4.88M	-283.00%	-186.40%	-392.88%	-398.60%	0.91	3.21	N/A	N/A	N/A
APRE	APREA THERAPEUTICS INC	$8.27M	-78.90%	-62.70%	-105.05%	583.10%	0.29	5.34	100.00%	-1,646.80%	-1,766.47%
ARMP	ARMATA PHARMACEUTICALS INC	$114.85M	N/A	-29.20%	30.78%	-11.40%	-2.16	0.06	100.00%	-610.90%	-287.40%
CARM	CARISMA THERAPEUTICS INC	$6.44M	N/A	-137.40%	-931.22%	-1,452.40%	-1.44	1.34	100.00%	-254.30%	-256.83%
ASRT	ASSERTIO HOLDINGS INC	$80.36M	-38.20%	-15.40%	-28.43%	-48.10%	1.93	1.59	67.90%	-37.00%	-34.30%
ADVB	ADVANCED BIOMED INC	$10.60M	-139.90%	-54.80%	-89.95%	398.80%	0.87	2.09	N/A	N/A	N/A
ANTX	AN2 THERAPEUTICS INC	$34.43M	-48.00%	-43.10%	-54.30%	-68.40%	0.10	9.67	N/A	N/A	N/A
ALUR	ALLURION TECHNOLOGIES INC	$15.53M	N/A	-57.20%	-125.31%	-25.30%	-1.44	2.02	61.80%	-107.70%	-104.15%
IKT	INHIBIKASE THERAPEUTICS INC	$119.97M	-63.80%	-58.00%	-51.85%	-319.40%	0.11	10.09	N/A	N/A	N/A
IMCC	IM CANNABIS CORP	$7.81M	-22.50%	-2.70%	84.06%	49.40%	10.51	0.72	24.20%	-2.20%	9.50%
BRTX	BIORESTORATIVE THERAPIES INC	$12.92M	-145.30%	-93.90%	-221.32%	-192.50%	0.76	2.07	94.50%	-1,771.90%	-1,771.91%
KTTA	PASITHEA THERAPEUTICS CORP	$5.58M	-88.60%	-81.10%	-88.11%	4,718.40%	0.12	4.97	N/A	N/A	N/A
AKAN	AKANDA CORP	$1.59M	-56.60%	-27.50%	-66.04%	-3,415.80%	0.88	1.26	9.60%	-619.50%	-619.14%
CNSP	CNS PHARMACEUTICALS INC	$5.58M	-183.90%	-139.40%	-117.66%	1,437.20%	0.11	10.22	N/A	N/A	N/A
AKRO	AKERO THERAPEUTICS INC	$4.30B	-32.00%	-29.40%	-23.77%	-42.40%	0.07	16.80	N/A	N/A	N/A
COCH	ENVOY MEDICAL INC	$19.05M	N/A	-273.70%	-1,026.26%	-101.80%	-1.33	0.94	-262.20%	-12,704.50%	-8,783.33%
CODX	CO-DIAGNOSTICS INC	$14.60M	-69.50%	-60.50%	-84.09%	-155.10%	0.13	4.13	39.60%	-3,586.00%	-3,582.18%
AHG	AKSO HEALTH GROUP	$882.09M	-80.00%	-75.60%	-82.42%	-557.00%	0.08	14.20	-1.90%	-913.40%	-1,121.81%
AIM	AIM IMMUNOTECH INC	$6.83M	N/A	-198.50%	248.39%	683.60%	-1.63	0.10	71.10%	-13,360.30%	-12,858.68%
ACON	ACLARION INC	$5.01M	-84.40%	-77.30%	-48.78%	2,399.00%	0.04	23.81	-26.40%	-11,215.90%	-10,996.43%
DRTS	ALPHA TAU MEDICAL LTD	$321.46M	-51.20%	-38.20%	-31.98%	-37.50%	0.28	10.52	N/A	N/A	N/A
EVGN	EVOGENE LTD	$11.24M	N/A	-38.50%	-53.84%	-87.80%	-14.85	1.89	13.90%	-385.20%	-272.59%
ADAG	ADAGENE INC	$91.91M	-63.30%	-35.70%	-76.75%	184.60%	0.76	2.29	100.00%	-28,961.70%	-28,260.68%
ADIL	ADIAL PHARMACEUTICALS INC	$8.32M	-191.30%	-153.60%	-151.14%	-8,040.80%	0.22	5.02	N/A	N/A	N/A
FONR	FONAR CORP	$102.87M	4.60%	3.70%	5.74%	6.50%	0.33	8.45	41.10%	7.50%	10.99%
ADGM	ADAGIO MEDICAL HOLDINGS INC	$31.07M	-222.60%	-112.40%	-203.07%	-361.10%	3.14	2.50	-841.30%	-24,320.80%	-23,396.28%
GDTC	CYTOMED THERAPEUTICS LTD	$23.77M	-42.40%	-38.10%	-47.70%	-75.20%	0.16	5.81	84.10%	-1,629.20%	-1,619.98%
GLMD	GALMED PHARMACEUTICALS LTD	$7.53M	-48.30%	-43.00%	-45.36%	-78.30%	0.12	8.71	N/A	N/A	N/A
ADAP	ADAPTIMMUNE THERAPEUTICS PLC	$49.13M	N/A	-79.70%	-202.70%	-112.90%	-2.84	1.52	94.70%	-260.80%	-246.42%
IMMP	IMMUTEP LTD	$292.57M	-36.90%	-34.30%	-42.57%	-130.80%	0.09	11.69	100.00%	-594.60%	-594.28%
INNV	INNOVAGE HOLDING CORP	$693.11M	-12.30%	-5.70%	-6.74%	-9.00%	1.12	1.07	18.00%	-3.60%	-2.86%
PIII	P3 HEALTH PARTNERS INC	$66.12M	-192.00%	-18.60%	-48.64%	81.00%	14.49	0.31	-8.00%	-10.00%	-7.54%
SRXH	SRX HEALTH SOLUTIONS INC	$8.20M	N/A	-78.20%	41.92%	-386.40%	-1.74	0.33	34.80%	-43.30%	-45.29%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	626	-2.11%	+1.43%	+11.13%	-19.81%	-100.83x	4.91x	-101.57%	-7.59%	-14.89%	+65.40%	Strong Buy
Diagnostics & Research	56	-2.08%	-2.92%	+4.73%	-6.80%	22.57x	3.97x	-3.13%	+7.03%	+15.03%	+8.73%	Buy
Drug Manufacturers - General	20	-1.66%	-1.69%	+5.99%	-3.35%	40.09x	6.40x	+60.52%	+10.51%	+18.08%	+8.35%	Buy
Drug Manufacturers - Specialty & Generic	77	-2.64%	-3.53%	-4.98%	-19.17%	-38.95x	2.19x	+10.81%	+4.01%	+9.37%	+41.69%	Strong Buy
Healthcare Plans	10	-2.57%	-1.77%	+5.29%	-25.28%	15.49x	2.11x	+15.81%	+4.97%	+11.52%	+11.72%	Buy
Health Information Services	55	-4.05%	-3.03%	+0.22%	-51.59%	72.97x	4.50x	-43.92%	-1.35%	+2.53%	+27.08%	Strong Buy
Medical Care Facilities	48	-1.49%	-3.40%	+0.63%	-25.73%	16.50x	4.94x	-184.46%	+6.88%	+15.32%	+18.18%	Buy
Medical Devices	140	-2.64%	-2.81%	-2.51%	-26.38%	29.47x	3.89x	+13.76%	+8.54%	+10.06%	+31.94%	Strong Buy
Medical Distribution	11	+0.55%	+2.99%	+6.97%	+39.93%	29.25x	315.69x	-8.82%	+3.12%	+19.06%	+10.92%	Buy
Medical Instruments & Supplies	56	-2.41%	-4.22%	-2.97%	-61.81%	32.91x	3.29x	+10.51%	+8.43%	+11.13%	+27.41%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Oct 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the #1 top healthcare stock out of 1099 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Embecta (NASDAQ:EMBC) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: D, Financials: A, and AI: C.

Embecta (NASDAQ:EMBC) has a Due Diligence Score of 35, which is 10 points higher than the healthcare sector average of 25. It passed 12 out of 38 due diligence checks and has average fundamentals. Embecta has seen its stock return 7.3% over the past year, overperforming other healthcare stocks by 33 percentage points.

Embecta has an average 1 year price target of $18.50, an upside of 38.27% from Embecta's current stock price of $13.38.

Embecta stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Embecta, 50% have issued a Strong Buy rating, 0% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

Amneal Pharmaceuticals (NASDAQ:AMRX) is the #2 top healthcare stock out of 1099 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Amneal Pharmaceuticals (NASDAQ:AMRX) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: B, and AI: C.

Amneal Pharmaceuticals (NASDAQ:AMRX) has a Due Diligence Score of 37, which is 12 points higher than the healthcare sector average of 25. It passed 12 out of 33 due diligence checks and has average fundamentals. Amneal Pharmaceuticals has seen its stock return 17.85% over the past year, overperforming other healthcare stocks by 43 percentage points.

Amneal Pharmaceuticals has an average 1 year price target of $14.00, an upside of 40.42% from Amneal Pharmaceuticals's current stock price of $9.97.

Amneal Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Amneal Pharmaceuticals, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharmaceuticals (NASDAQ:AUPH) is the #3 top healthcare stock out of 1099 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Aurinia Pharmaceuticals (NASDAQ:AUPH) is: Value: A, Growth: C, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: B.

Aurinia Pharmaceuticals (NASDAQ:AUPH) has a Due Diligence Score of 47, which is 22 points higher than the healthcare sector average of 25. It passed 15 out of 33 due diligence checks and has strong fundamentals. Aurinia Pharmaceuticals has seen its stock return 61.46% over the past year, overperforming other healthcare stocks by 87 percentage points.

Aurinia Pharmaceuticals has an average 1 year price target of $13.00, an upside of 15.35% from Aurinia Pharmaceuticals's current stock price of $11.27.

Aurinia Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Aurinia Pharmaceuticals, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 70 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Select Medical Holdings (NYSE:SEM)

Select Medical Holdings (NYSE:SEM) has an annual dividend yield of 13.81%, which is 12 percentage points higher than the healthcare sector average of 2.11%. Select Medical Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Select Medical Holdings's dividend has not shown consistent growth over the last 10 years.

Select Medical Holdings's dividend payout ratio of 35.1% indicates that its high dividend yield is sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 9.46%, which is 7 percentage points higher than the healthcare sector average of 2.11%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8%, which is 6 percentage points higher than the healthcare sector average of 2.11%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 150.6% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -2.14% in the last day, and down -1.26% over the last week. Xenetic Biosciences was the among the top losers in the healthcare sector, dropping -33.09% yesterday.

Xenetic Biosciences shares are trading lower after the company announced the pricing of a $4.5 million offering of 735,000 shares at $6.12 per share.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 55 points higher than the healthcare sector average of 16. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -23.76% in the past year. It has overperformed other stocks in the healthcare sector by 2 percentage points.

2. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 41 points higher than the healthcare sector average of 16. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has gained 7.3% in the past year. It has overperformed other stocks in the healthcare sector by 33 percentage points.

3. Auna Sa (NYSE:AUNA)

Auna Sa (NYSE:AUNA) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Auna Sa has a valuation score of 29, which is 13 points higher than the healthcare sector average of 16. It passed 2 out of 7 valuation due diligence checks.

Auna Sa's stock has dropped -5.48% in the past year. It has overperformed other stocks in the healthcare sector by 20 percentage points.

Are healthcare stocks a good buy now?

52.9% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 34.8% over the next year.

5.15% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.4% of healthcare stocks are rated B (Buy), 48.42% are rated C (Hold), 23.98% are rated D (Sell), and 10.06% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 10.02x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Embecta (NASDAQ:EMBC)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aurinia Pharmaceuticals (NASDAQ:AUPH)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2025)Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Embecta (NASDAQ:EMBC)

2. Amneal Pharmaceuticals (NASDAQ:AMRX)

3. Aurinia Pharmaceuticals (NASDAQ:AUPH)

1. Select Medical Holdings (NYSE:SEM)

2. Dominari Holdings (NASDAQ:DOMH)

3. Spok Holdings (NASDAQ:SPOK)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Embecta (NASDAQ:EMBC)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2025)
Top healthcare stocks in 2025 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.